Abstract
Endothelial cell injury is considered to play a critical role for development and progression of atherosclerosis as well as for complications after percutaneous coronary artery interventions in patients with coronary disease. Through the course of human life, the endothelium is constantly replaced and exposure to endothelial cell damaging stimuli, such as cardiovascular risk factors, requires a substantially faster repair and replacement response in order to maintain endothelial integrity and function. Moreover, after coronary interventions, the induced vascular injury requires a fast and efficient re-endothelialization in order to prevent thrombotic events. The promotion of endothelial repair and re-endothelialization responses in patients with cardiovascular disease is therefore a therapeutic target of high interest.
In this review we will critically summarize novel insights into the vascular repair process, as well as the tightly linked mechanisms of adverse vascular remodeling. We will address the roles of resident vascular cell types, as well as circulating mononuclear cell populations, microvesicles and soluble mediators for the vascular repair response.
A better understanding of the mechanisms limiting vascular repair in patients with cardiovascular disease may provide novel opportunities for therapeutic interventions aiming to promote the maintenance of vascular integrity.
Keywords: Endothelium, vascular repair, vascular lesion, vascular injury, adverse remodeling.
Current Pharmaceutical Design
Title:Novel Insights into Vascular Repair Mechanisms
Volume: 20 Issue: 14
Author(s): Nicolle Krankel, Thomas F. Luscher and Ulf Landmesser
Affiliation:
Keywords: Endothelium, vascular repair, vascular lesion, vascular injury, adverse remodeling.
Abstract: Endothelial cell injury is considered to play a critical role for development and progression of atherosclerosis as well as for complications after percutaneous coronary artery interventions in patients with coronary disease. Through the course of human life, the endothelium is constantly replaced and exposure to endothelial cell damaging stimuli, such as cardiovascular risk factors, requires a substantially faster repair and replacement response in order to maintain endothelial integrity and function. Moreover, after coronary interventions, the induced vascular injury requires a fast and efficient re-endothelialization in order to prevent thrombotic events. The promotion of endothelial repair and re-endothelialization responses in patients with cardiovascular disease is therefore a therapeutic target of high interest.
In this review we will critically summarize novel insights into the vascular repair process, as well as the tightly linked mechanisms of adverse vascular remodeling. We will address the roles of resident vascular cell types, as well as circulating mononuclear cell populations, microvesicles and soluble mediators for the vascular repair response.
A better understanding of the mechanisms limiting vascular repair in patients with cardiovascular disease may provide novel opportunities for therapeutic interventions aiming to promote the maintenance of vascular integrity.
Export Options
About this article
Cite this article as:
Krankel Nicolle, Luscher F. Thomas and Landmesser Ulf, Novel Insights into Vascular Repair Mechanisms, Current Pharmaceutical Design 2014; 20 (14) . https://dx.doi.org/10.2174/13816128113199990478
DOI https://dx.doi.org/10.2174/13816128113199990478 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Multidisciplinary Pharmaceutical Drug Design Strategies in the Progress of Drug Discovery"
The process of developing a drug is time- and money-consuming, but also fascinating. The development of numerous computational techniques, synthetic methodologies, formulation-based drug discovery, etc. has improved the drug discovery process. The process of developing new drugs is significantly hampered by drug-poor pharmacodynamics and pharmacokinetic problems. To address these challenges, ...read more
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employed in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, and prediction, to monitoring of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Neurotrophins in Axonal Growth, Guidance, and Regeneration
Current Neurovascular Research Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy
Current Cancer Drug Targets Computational Approaches for the Identification and Optimization of Src Family Kinases Inhibitors
Current Medicinal Chemistry Editorial (Hot Topics: Naturally Occurring Molecules and Anticancer Combination Therapies in the Era of Personalized Medicine and Economic Crisis)
Current Pharmaceutical Design Synthesis and Antitumor Activity Evaluation of 2-Aminothiazoles Appended 5-methylisoxazoline and Pyridine-piperazine Hybrid Molecules
Letters in Organic Chemistry Anticancer Activity of Polyether Ionophore-Salinomycin
Anti-Cancer Agents in Medicinal Chemistry Investigative Approaches for Oral Delivery of Anticancer Drugs: A Patent Review
Recent Patents on Drug Delivery & Formulation The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunates Activity in Cancer Cells
Current Cancer Drug Targets Ultrasound Diagnosis of Soft Tissue Vascular Malformations and Tumours
Current Medical Imaging Editorial: [Hot Topic: Central Nervous System Drugs in the Treatment of Neurological Disorders]
Central Nervous System Agents in Medicinal Chemistry Adjuvant and Neoadjuvant Chemotherapy for Soft Tissue Sarcomas
Current Medicinal Chemistry C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside
Current Neuropharmacology Invasive Pulmonary Aspergillosis in Acute Leukemia: Current Issues for Pathogenesis, Diagnosis and Treatment
Current Respiratory Medicine Reviews 2,3-Dichloro-1,4-Naphthoquinone in Organic Synthesis: Recent Advances
Mini-Reviews in Organic Chemistry The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
Current Cancer Drug Targets Application of Charge Transfer Reactions for the Quantitative Spectrophotometric Determination of Cyclophosphamide in Pure and Pharmaceutical Formulation
Current Pharmaceutical Analysis Carvedilol: Just Another Beta-Blocker or a Powerful Cardioprotector?
Cardiovascular & Hematological Disorders-Drug Targets Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery Recent Advance in the Research of Flavonoids as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in Cancer
Recent Patents on Anti-Cancer Drug Discovery